Avita Medical (RCEL) News
NASDAQ: RCELHealth CareMedical/Dental InstrumentsUSD
15.62-0.37 (-2.31%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
RCEL news summary
We found 9 recent headlines mentioning Avita Medical (RCEL): 1 in the past week and 6 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, RCEL is down 2.31% at $15.62. The most recent story, "AVITA Medical Reports Complete Cohealyx I Data in Full-Thickness Wounds Showing Earlier Graft Readiness and Six-Month Healing Outcomes", was published by GlobeNewswire on Nov 16, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Avita Medical headlines
- AVITA Medical Reports Complete Cohealyx I Data in Full-Thickness Wounds Showing Earlier Graft Readiness and Six-Month Healing OutcomesComplete Cohealyx I data show earlier graft readiness, healing and improved scar scores through six months with no product-related adverse events reportedGlobeNewswire
- AVITA Medical Consensus Price Target Increased by 48.78% to $20.74The average one-year price target for AVITA Medical (NASDAQCM:RCEL) (DB:51KA) has been revised to $20.74 / share. This is an increase of 48.78% from the prior estimate of $13.94 dated October 30,…Nasdaq
- AVITA Medical to Host Investor Webinar BriefingAVITA Medical to Host Investor Webinar BriefingGlobeNewswire
- AVITA Medical (RCEL) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- AVITA Medical Announces National Medicare Physician Payment Framework and Simplified Billing Codes for RECELL Procedures in 2027The Centers for Medicare & Medicaid Services finalized national physician payment values and simplified billing codes for RECELL proceduresGlobeNewswire
- AVITA Medical Consensus Price Target Increased 10.81% to $13.94The average one-year price target for AVITA Medical (NASDAQCM:RCEL) (DB:51KA) has been revised to $13.94 / share. This is an increase of 10.81% from the prior estimate of $12.58 dated October 20,…Nasdaq
- AVITA Medical to Announce Third Quarter 2026 Financial ResultsAVITA Medical to report its third quarter 2026 financial results on Thursday November 5, 2026GlobeNewswire
- Biotech Stocks At 52-Week Highs - HUM +11%, MRNA +14%, PBYI, ABBV, RCEL(RTTNews) - The following biotech stocks reached a 52-week high on October 9, 2026, driven by catalysts such as achieving new regulatory milestones.NasdaqABBV, HUM, MRNA, PBYI
- Biotech Stocks At 52-Week Highs - CDNA, RCEL, AZTA, HNGE(RTTNews) - The following biotech stocks reached a 52-week high on October 2, 2026, driven by key catalysts such as encouraging quarterly reports.NasdaqAZTA, CDNA, HNGE, RCEL